I wanted this to be great and it was... fine. There's a lot of politics and competitiveness, which is interesting. I also liked the parts about how different scientists enjoy the business side of things and, especially, how Stanford does a great job of helping their faculty and doctorate students make money. Berkeley, where Doudna is, is doing its best to keep up. Isaacson's discussion on the moral aspects of using CRISPR on humans, how different cultures may view this, and the practice in humans to date – only in China – was excellent.